21,202 results on '"Pharmaceutical industry -- Research"'
Search Results
2. Merck KGaA, Darmstadt, Germany and Intel Introduce Academic Research Program in Europe
3. Merck KGaA, Darmstadt, Germany and Intel Roll Out Academic Research Program in Europe
4. Studies from Georgetown University Yield New Data on Type 2 Diabetes (Manufacturer-sponsored Drug Coupon Use and Drug-switching Behavior Among Patients With Type 2 Diabetes)
5. Findings from Indiana University School of Medicine Provides New Data about Cancer (Impact of Optimized Ku-dna Binding Inhibitors On the Cellular and In Vivo Dna Damage Response)
6. Study Findings on Salmonella typhi Are Outlined in Reports from Technical University of Denmark (DTU) (The dynamics of bla TEM resistance genes in Salmonella Typhi)
7. Researchers at PTC Therapeutics Inc. Have Reported New Data on Gene Therapy (Preclinical Studies of Gene Replacement Therapy for Cdkl5 Deficiency Disorder)
8. New Cancer Study Findings Reported from University of California San Francisco (UCSF) (Patient Counts: a Pilot Navigation Program for Asian American Cancer Patients)
9. Research Reports on Hepatitis B Virus from Medical University of Innsbruck Provide New Insights (Anti-HBs Seroprevalence in Blood Donors from Tyrol, Austria)
10. Reports on Prostate Cancer from Memorial Sloan-Kettering Cancer Center Provide New Insights [177lu-psma-617 Versus a Change of Androgen Receptor Pathway Inhibitor Therapy for Taxane-naive Patients With Progressive Metastatic ...]
11. New Findings from University of Maryland Update Understanding of Stroke (Mildly Elevated Inr Is Associated With Worse Outcomes Following Mechanical Thrombectomy for Acute Ischemic Stroke)
12. Findings from Eulji University Broaden Understanding of Type 2 Diabetes (Efficacy and Safety of Enavogliflozin Versus Dapagliflozin As Add-on To Metformin In Patients With Type 2 Diabetes Mellitus: a 24-week, Double-blind, Randomized Trial)
13. Findings from Tulane University in the Area of Obesity Described (Body Mass Index As a Determinant of Scar Formation Post-af Ablation: Insights From Decaaf Ii)
14. Johnson & Johnson says Impella ECP met primary endpoint in high-risk PCI study
15. Johnson & Johnson's Tremfya shows efficacy in Crohn's disease Phase 3 study
16. Eli Lilly announces results from two, multi-year mirikizumab studies
17. Study Findings on Acute Pancreatitis Reported by a Researcher at Arrowhead Pharmaceuticals [Plozasiran (Aro-apoc3), An Investigational Rnai, Demonstrates Deep And Durable Tg Reductions in Patients With Shtg, Shasta-2 Final Results]
18. Research Results from AbbVie Inc. Update Knowledge of Ulcerative Colitis (Crohn's disease and ulcerative colitis share two molecular subtypes with different mechanisms and drug response)
19. Study Findings from Queen Mary University of London Update Knowledge in Antimicrobials [Adopting prospective antimicrobial stewardship (AMS) practice in high-risk immunosuppressed groups: an urgent call to action in the era of antimicrobial ...]
20. Research from University Children's Hospital Zurich Reveals New Findings on Glycogen Storage Disease (Living with Pompe disease: results from a qualitative interview study with children and adolescents and their caregivers)
21. Johannes Gutenberg University Medical Center Mainz Researchers Publish New Studies and Findings in the Area of Liver Fibrosis (Inflammation in liver fibrosis and atrial fibrillation: A prospective population-based proteomic study)
22. Investigators from Pfizer Zero in on Life Science (Process Development for the First Gmp Synthesis of Sgd-9501-tfa, Part 1: Synthesis of Two Oligopeptide Fragments)
23. Findings from Alkermes Inc. Broaden Understanding of Veterans (Treatment Journey and Healthcare Resource Use Among Patients With Alcohol Use Disorder Who Initiated Extended-Release Naltrexone: An Analysis of Veterans Affairs Data)
24. Bayer to present latest research on impact and burden of menopause symptoms at IMS 2024
25. Reports Outline Solid Cancer Study Results from Chungbuk National University [A Phase Ii Study of Tepotinib In Patients With Advanced Solid Cancers Harboring Met Exon 14 Skipping Mutations or Amplification Fi Cation (Kcsg Al19-17)]
26. Novartis Researcher Details Findings in Biopharmaceuticals (Alternative buffer systems in biopharmaceutical formulations and their effect on protein stability)
27. New Enzymes and Coenzymes Research from Sorbonne University Described (High prevalence of NTRK fusions in sporadic dMMR/MSI mCRC RAS/RAF wild-type: an opportunity for a post-immune checkpoint inhibitors progression rescue strategy)
28. Findings from Regeneron Pharmaceuticals Inc. in Lipoproteins Reported [Low prevalence of testing for apolipoprotein B and lipoprotein (a) in the real world]
29. New Alopecia Areata Study Findings Reported from Pfizer (Hair Regrowth In Alopecia Areata and Re-pigmentation In Vitiligo In Response To Treatment: Commonalities and Differences)
30. New Data from Royal North Shore Hospital Illuminate Research in Kinase Inhibitors (ALKTERNATE: A Pilot Study Alternating Lorlatinib With Crizotinib in ALK-Positive NSCLC With Prior ALK Inhibitor Resistance)
31. AstraZeneca Researcher Reports on Findings in Pharmacy and Pharmacology (Pharmacokinetics of nano- and microcrystal formulations of low solubility compounds after intramuscular injection to mice)
32. Study Results from Duke University Provide New Insights into Prostate Cancer (Androgen Receptor Inhibitors In Patients With Nonmetastatic Castration-resistant Prostate Cancer)
33. Studies from Goethe-University Frankfurt Yield New Data on Cardiovascular Diseases and Conditions (Fapi-pet In Cardiovascular Disease)
34. University of Copenhagen Researchers Update Current Data on Gestational Diabetes (Maternal glucose homeostasis during pregnancy in women with overweight or obesity and offspring metabolic health)
35. Research Reports from University of the Gambia Provide New Insights into Cervical Intraepithelial Neoplasia (Human papillomavirus type-specific distribution in cervical intraepithelial neoplasia and cancer in The Gambia prior to HPV ...)
36. Data from Pfizer Advance Knowledge in Breast Cancer (Patterns and Outcomes In Hr+/her2-advanced/metastatic Breast Cancer Patients In Brazil Receiving Palbociclib)
37. Study Results from Regeneron Pharmaceuticals Inc. Broaden Understanding of Science Immunology (IgE plasma cells are transcriptionally and functionally distinct from other isotypes)
38. Studies from Bambino Gesu Children's Hospital Update Current Data on Hemolytic Uremic Syndrome (An Expert Discussion On the Atypical Hemolytic Uremic Syndrome Nomenclature- - Identifying a Road Map To Precision: a Report of a National Kidney ...)
39. New Urticaria Study Findings Have Been Reported by Investigators at Sanofi (Twenty-five Fi Ve Years: the Fexofenadine Clinical Experience)
40. J&J says Phase 3 CEPHEUS study meets primary endpoint
41. Pharma manufacturing and research utilize AI to reduce human error and speed up drug discovery
42. Studies Conducted at Kyoto University on Type 2 Diabetes Recently Reported (Pioneer Real Japan: Primary Results From a Multicenter, Prospective, Real-world Study of Oral Semaglutide In Adults With Type 2 Diabetes In Japanese Clinical Practice)
43. Findings on Antimicrobials Detailed by Investigators at Keio University (Antimicrobial Stewardship of Oral Third-generation Cephalosporins In Community Pharmacy: a Single-center Quasi-experimental Study)
44. Findings from AstraZeneca Provides New Data about Biotechnology (Improved Clearance of Host Cell Protein Impurities At the Polishing Purification Step Using Multimodal Chromatography)
45. Researcher at Brigham and Women's Hospital Details Research in COVID-19 (Obesity and age are transmission risk factors for SARS-CoV-2 infection among exposed individuals)
46. Reports Outline Cytokines Study Results from Trinity College Dublin (Evolutionary Analysis of the Mammalian Il-17 Cytokine Family Suggests Conserved Roles In Female Fertility)
47. J&J seeks EU approval of nipocalimab to treat people living with generalised myasthenia gravis
48. Studies from University Libre of Bruxelles (U.L.B.) Have Provided New Data on Breast Cancer (Effect of Cyclin-Dependent Kinase 4/6 Inhibitors on Circulating Cells in Patients with Metastatic Breast Cancer)
49. Sanofi Researchers Release New Study Findings on Cardiovascular Agents (Bioavailability of dronedarone tablets administered with or without food in healthy participants)
50. Researchers from Daiichi Sankyo Inc. Describe Research in Kinase Inhibitors (Treatment Patterns and Resource Use After Osimertinib Discontinuation in Patients with EGFR + Metastatic NSCLC)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.